Literature DB >> 3801762

Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis.

G S Brindley.   

Abstract

Seven drugs that are known to relax smooth muscle (phenoxybenzamine, phentolamine, thymoxamine, imipramine, verapamil, papaverine, naftidrofuryl) caused erection when injected intracavernosally. Salbutamol, hydralazine, lignocaine and bupivacaine caused tumidity but not erection. Metaraminol and guanethidine caused shrinkage followed by tumidity. Neostigmine, atropine, propranolol and idazoxan had no effect in the doses tried. It is argued that the seven drugs that cause erection do so by relaxing vascular and trabecular smooth muscle within the cavernosal space, and that the two that cause shrinkage of the penis do so by constricting vascular and trabecular smooth muscle within the cavernosal space. It is argued that muscarinic and beta-adrenergic transmission play no important part in erectile mechanisms within the corpora cavernosa. Papaverine, phenoxybenzamine and metaraminol, given intracavernosally, are already used therapeutically. Uses are suggested for thymoxamine, phentolamine, verapamil and guanethidine.

Entities:  

Mesh:

Year:  1986        PMID: 3801762      PMCID: PMC1916566          DOI: 10.1111/j.1476-5381.1986.tb10191.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Proceedings: The effect of atropine on the urinary bladder of the baboon and of man.

Authors:  G S Brindley; M D Craggs
Journal:  J Physiol       Date:  1976-03       Impact factor: 5.182

2.  Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.

Authors:  A W Zorgniotti; R S Lefleur
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

3.  Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man.

Authors:  J G Collier; R E Lorge; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

4.  New treatment for priapism.

Authors:  G S Brindley
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

5.  Metaraminol for priapism.

Authors:  A Stanners; D Colin-Jones
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

6.  Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.

Authors:  R Virag; D Frydman; M Legman; H Virag
Journal:  Angiology       Date:  1984-02       Impact factor: 3.619

7.  Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.

Authors:  G S Brindley
Journal:  Br J Psychiatry       Date:  1983-10       Impact factor: 9.319

  7 in total
  17 in total

1.  Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.

Authors:  K Hallén; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

2.  Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.

Authors:  K Mann; T Klingler; S Noe; J Röschke; S Müller; O Benkert
Journal:  Arch Sex Behav       Date:  1996-02

Review 3.  New developments in the diagnosis and treatment of impotence.

Authors:  R G De Palma
Journal:  West J Med       Date:  1996-01

4.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 5.  Impotence: diagnosis and management of male erectile dysfunction.

Authors:  R S Kirby
Journal:  BMJ       Date:  1994-04-09

6.  Evaluating the effects of an alpha-2 adrenoceptor antagonist on erectile function in the human male. 1. The erectile response to erotic stimuli in volunteers.

Authors:  M Munoz; J Bancroft; M Turner
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

7.  Intracavernosal metaraminol for treatment of intraoperative penile erection.

Authors:  S K Tsai; C Y Hong
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

8.  Inhibition of nerve stimulation-induced vasodilatation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase.

Authors:  J P Finberg; S Levy; Y Vardi
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Autonomic control of penile erection in the dog.

Authors:  C J Carati; K E Creed; E J Keogh
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

10.  Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: role of charybdotoxin-sensitive K(+)-channels.

Authors:  U Simonsen; D Prieto; I Sánez de Tejada; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.